Skip to content

Clinical trials

Completed Observational Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Status: Completed Clear all

582 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20013
20026
200312
200412
200515
200623
200713
200826
200922
201032
201120
201235
201324
201432
201529
201635
201731
201832
201927
202035
202136
202222
202316
202410
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed582

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center25
Memorial Sloan Kettering Cancer Center20
National Cancer Institute (NCI)19
AstraZeneca16
Alliance for Clinical Trials in Oncology14
Mayo Clinic12
National Taiwan University Hospital7
University Health Network, Toronto7
Bristol-Myers Squibb6
ECOG-ACRIN Cancer Research Group6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms582
Carcinoma, Non-Small-Cell Lung118
Breast Neoplasms74
Colorectal Neoplasms39
Neoplasms39
Prostatic Neoplasms34
Small Cell Lung Carcinoma31
Colonic Neoplasms29
Esophageal Neoplasms29
Head and Neck Neoplasms29

Trials

Showing 1 to 25 of 582. Each trial links to its page on Pharma Observatory.

482 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.